A California alternative medical clinic has since at least 2017 offered regenerative stem cell therapies to treat ailments like arthritis without fear of patent infringement. But after Regen Labs LLC and affiliated clinics performed over 12,000 stem cell treatments, the provider was sued.
Biotech firm VetStem Inc. accused Regen Labs of infringing patents related to stem cell treatments. The clinic invoked immunity from patent infringement under the US Patent Act, but a California federal judge denied the effort.
It was one of two federal courts that rejected physician immunity claims in July, casting doubt over the breadth of medical clinics’ ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.